Crestor Articles
Stock Commentary - Europe
16 February 2004
AstraZeneca forecasts sharp rise in earnings but shares slip on mediocre Crestor sales
9 February 2004
MS analysts revise AstraZeneca's outlook
26 January 2004
New Chemical Entities in 2003
19 January 2004
Stock Commentary - Europe
19 January 2004
NDAs rise 20% as R&D, marketing unite: study
22 December 2003
Stock Commentary - Europe
17 November 2003
As R&D and marketing unite, NME numbers rise: study
3 November 2003
Stock Commentary - Europe
27 October 2003
AstraZeneca profits likely down in 3rd qtr?
27 October 2003
Crestor sales could be crimped by WellPoint
20 October 2003
Stock Commentary - Europe
13 October 2003
Stock Commentary - Tokyo
29 September 2003
Tokyo pharma stocks - week to Sept 22
29 September 2003
Stock Commentary - Europe
8 September 2003
AstraZeneca's Crestor - new hope for metabolic syndrome
8 September 2003
Tokyo pharma stocks - week to August 11
18 August 2003
Tokyo pharma stocks - week to July 28
4 August 2003
Stock Commentary - Europe
21 July 2003
Tokyo pharma stocks - week to July 14
21 July 2003
Stock Commentary - Europe
14 July 2003
Stock Commentary - Europe
2 June 2003
AstraZeneca new facility inaugurated
2 June 2003
Crestor advisory panel raises fears of delay
26 May 2003
Tokyo pharma stocks - week to May 5
12 May 2003
Update - AstraZeneca 's Crestor: ACC studies
7 April 2003
AstraZeneca initiates Crestor JUPITER study
24 March 2003
Stock Commentary - Europe
17 March 2003
First Euro launch for Crestor in Netherlands
10 March 2003
First launch, in Canada, for AstraZeneca's superstatin Crestor
24 February 2003
AstraZeneca EPS set to fall in 2003
3 February 2003
Stock Commentary - New York
19 August 2002
Stock Commentary - Europe
19 August 2002
Tokyo pharma stocks - week to August 12
19 August 2002
Crestor data to be filed in 2003; no launch this year
12 August 2002
Stock Commentary - Europe
5 August 2002
Tokyo pharma stocks - week to July 29
5 August 2002
Stock Commentary - Europe
29 July 2002
AstraZeneca's Crestor looks set for delay
29 July 2002
Tokyo pharma stocks - week to July 15
22 July 2002
Stock Commentary - Europe
22 July 2002
New Crestor results reinforce profile
15 July 2002
Japanese stock market - week to July 1
8 July 2002
Tokyo pharma stocks - week to June 10
17 June 2002
Stock Commentary - Tokyo
10 June 2002
Tokyo pharma stocks - week to May 20
27 May 2002
Shionogi to co-market Crestor in Japan
27 May 2002
Stock Commentary - Europe
13 May 2002
Stock Commentary - Europe
6 May 2002
Tokyo pharma stocks - week to April 29
6 May 2002
AstraZeneca confident about overcoming loss of Prilosec revenues
11 February 2002
"Robust" year for AstraZeneca
5 December 2001
Klinge Pharma takes over fluvastatin in Germany
14 September 2001
Analysts comment on Crestor safety data
14 September 2001
Crestor "as safe as other statins"
13 September 2001
Stock Commentary - Europe
13 September 2001
Stock Commentary - Tokyo
6 September 2001
Japan pharma stocks, week to Sept 3rd
5 September 2001
Stock Commentary - Europe
16 August 2001
Japan pharma stocks: week to August 13
14 August 2001
Stock Commentary - Europe
5 July 2001
Japan pharma stocks week to July 2, 2001
4 July 2001
AstraZeneca: Crestor filed, Viozan pulled
28 June 2001
Stock Commentary - Europe
31 May 2001
Japan pharma stock market week to May 21
23 May 2001
Crestor can protect blood vessels
21 May 2001
Novartis licenses super statin
26 April 2001
Stock Commentary - Europe
29 March 2001
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
